Patents Assigned to INSERM (Institut de la Sante er de la Recherche Medicale)
  • PROFILIN1:ACTIN INHIBITOR AS AN ANTI-ANGIOGENIC COMPOUND
    Publication number: 20230293490
    Abstract: Disclosed are anti-angiogenic agents that target Pfn1:actin interaction. Also disclosed are compounds for treating ocular diseases or conditions. Further disclosed are compounds for treating cancer.
    Type: Application
    Filed: August 12, 2021
    Publication date: September 21, 2023
    Applicants: University of Pittsburgh - Of the Commonwealth System of Higher Education, Sorbonne Université, Centre National de la Recherche Scientifique, INSERM (Institut de la Sante er de la Recherche Medicale)
    Inventors: Partha Roy, Lee McDermott, Abigail E. Allen, David Koes, David M. Gau, Paul G. Francoeur, Xavier Guillonneau